Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes - Summary - MDSpire
From the Journals

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

Registry-based analysis found no short-term advantage to changing therapy following ischemic stroke in patients with atrial fibrillation

Share

A multicenter study analyzed 1,006 patients with atrial fibrillation who experienced ischemic strokes while on direct oral anticoagulant (DOAC) therapy. Led by Dr. Lucio D'Anna, the research found no significant short-term benefits from switching oral anticoagulants after a breakthrough stroke compared to continuing the same DOAC. The primary outcome showed similar event rates for both groups concerning recurrent ischemic stroke and bleeding risks. Results challenge the assumption that switching anticoagulants improves outcomes.

Original Source(s)

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

  • by Andrea Surnit

  • April 30, 2026

Related Content

Cognition-Affecting Drugs Often Start in Acute Care

Older patients frequently continued these medication classes 1 year after initiation

Model May Reframe Tension-Type Headache

Proposed framework organizes interacting factors into four domains to guide personalized assessment

FDA Approves Auvelity for Agitation in Alzheimer’s Disease

The oral combination therapy expands treatment options for agitation associated with dementia due to Alzheimer’s disease.